(Reuters) – Novo Holdings has accomplished its $16.5 billion takeover of Catalent (NYSE:), the contract drugmaker stated on Wednesday, days after the businesses stated all regulatory situations to closing had been met. stuffed.
Novo Holdings is almost all shareholder of Danish drugmaker Novo Nordisk (NYSE:), which makes the blockbuster injectable GLP-1 weight reduction drug Wegovy.
#Novo #Holdings #completes #billion #takeover #Catalent #Reuters , #Gossip247
,
